Prostate Cancer

Latest News

Circulating biomarkers are prognostic for radium-223 benefit in mCRPC
Circulating biomarkers are prognostic for radium-223 benefit in mCRPC

March 27th 2024

“These results are encouraging and suggest that circulating biomarkers may be useful in guiding the use of radium-223 therapy,” says David T. Miyamoto, MD, PhD.

Galen Prostate demonstrates diagnostic value in prostate cancer
Galen Prostate demonstrates diagnostic value in prostate cancer

March 26th 2024

SBRT shows tolerability in high-risk and recurrent prostate cancer
SBRT shows tolerability in high-risk and recurrent prostate cancer

March 26th 2024

HSD3B1 CC genotype associated with inferior outcomes in prostate cancer
HSD3B1 CC genotype associated with inferior outcomes in prostate cancer

March 22nd 2024

EMA recommends approval of enzalutamide for nmHSPC
EMA recommends approval of enzalutamide for nmHSPC

March 22nd 2024

More News

© 2024 MJH Life Sciences

All rights reserved.